DBV Technologies (DBVT) EPS (Basic) Growth (1y) (2021 - 2026)
Powered by 
Analysis
DBV Technologies (DBVT) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 87.85% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 143.95% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 322.67% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -16.29% |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 96.41% |
| 10 | DBV Technologies | 5.86 Bn | 5.68 Bn | - | 62.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.69% |
| Mar 31, 2026 | 57.92% |
| Dec 31, 2025 | -35.36% |
| Sep 30, 2025 | 23.40% |
| Jun 30, 2025 | 9.52% |
| Mar 31, 2025 | 7.12% |
| Dec 31, 2024 | -101.77% |
| Sep 30, 2024 | -81.66% |
| Jun 30, 2024 | -33.98% |
| Mar 31, 2024 | -29.94% |
| Dec 31, 2023 | 76.81% |
| Sep 30, 2023 | 5.37% |
| Jun 30, 2023 | 26.32% |
| Mar 31, 2023 | 28.05% |
| Dec 31, 2022 | -103.69% |
| Sep 30, 2022 | 57.91% |
| Jun 30, 2022 | 37.52% |
| Mar 31, 2022 | 43.32% |
| Dec 31, 2021 | 65.89% |
| Sep 30, 2021 | 22.51% |